SCI Pharmtech Inc
TWSE:4119
SCI Pharmtech Inc
Intangible Assets
SCI Pharmtech Inc
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Intangible Assets
NT$37.8m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Intangible Assets
NT$39.4m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
0%
|
|
|
Formosa Laboratories Inc
TWSE:4746
|
Intangible Assets
NT$154.6m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
25%
|
|
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Intangible Assets
NT$17.1m
|
CAGR 3-Years
25%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-3%
|
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Intangible Assets
NT$7.8B
|
CAGR 3-Years
27%
|
CAGR 5-Years
22%
|
CAGR 10-Years
16%
|
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Intangible Assets
NT$33.8m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-14%
|
|
SCI Pharmtech Inc
Glance View
SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2002-08-12. The firm's main products include APIs, API intermediates and special and precision chemicals. The firm distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others
See Also
What is SCI Pharmtech Inc's Intangible Assets?
Intangible Assets
37.8m
TWD
Based on the financial report for Dec 31, 2024, SCI Pharmtech Inc's Intangible Assets amounts to 37.8m TWD.
What is SCI Pharmtech Inc's Intangible Assets growth rate?
Intangible Assets CAGR 5Y
-5%
Over the last year, the Intangible Assets growth was -18%. The average annual Intangible Assets growth rates for SCI Pharmtech Inc have been -14% over the past three years , -5% over the past five years .
You don't have any saved screeners yet